Duchenne Muscular Dystrophy (DMD)
Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy
12
The golden retriever model of Duchenne muscular dystrophy
21
Clinical utility of serum biomarkers in Duchenne muscular dystrophy
9
Duchenne muscular dystrophy (DMD) detail study
6
Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
6
Psychosocial Management of the Patient With Duchenne Muscular Dystrophy
13
Recent advances in Duchenne muscular dystrophy
24
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
8
Rehabilitation Management of the Patient With Duchenne Muscular Dystrophy
19
An Introduction to the Duchenne Muscular Dystrophy Care Considerations
6
Obesity and Endocrine Management of the Patient With Duchenne Muscular Dystrophy
12
Decreased Gait and Function in Duchenne Muscular Dystrophy
7
Fatigue in Children and Adolescents with Duchenne Muscular Dystrophy
187
Nutritional and Gastrointestinal Management of the Patient With Duchenne Muscular Dystrophy
11
Vascular-targeted therapies for Duchenne muscular dystrophy
12
Orthopedic and Surgical Management of the Patient With Duchenne Muscular Dystrophy
10
Biomarkers of Duchenne muscular dystrophy: current findings
13
Current and emerging treatment strategies for Duchenne muscular dystrophy
13
A Transition Toolkit for Duchenne Muscular Dystrophy
10
Computer task performance by subjects with Duchenne muscular dystrophy
8